Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2

Biochemical Pharmacology

Volumn 85, Issue 11, 2013, Pages 1619-1625

  Hu, Ya Peng ^a   Tao, Li Yang ^a   Wang, Fang ^a   Zhang, Jian Ye ^a   Liang, Yong Ju ^a   Fu, Li Wu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

ABCG2; Calpain 1; Multidrug resistance; Secalonic acid D; Side population

Indexed keywords

ABCC1 PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CALPAIN 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN; SECALONIC ACID D; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER RESISTANCE; CANCER STEM CELL; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIDE POPULATION CELL;

ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CALPAIN; CELL LINE, TUMOR; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XANTHONES;

EID: 84877597888     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.04.003     Document Type: Article

References (35)

1. T. Borovski, E.M.F. De Sousa, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res 71 2011 634 639
2. Y. Hu, and L. Fu Targeting cancer stem cells: a new therapy to cure cancer patients Am J Cancer Res 2 2012 340 356
3. M.M. Ho, A.V. Ng, S. Lam, and J.Y. Hung Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res 67 2007 4827 4833
4. M.A. Goodell, K. Brose, G. Paradis, A.S. Conner, and R.C. Mulligan Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo J Exp Med 183 1996 1797 1806
5. S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, and J.J. Morris The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat Med 7 2001 1028 1034
6. S. Zhou, J.J. Morris, Y. Barnes, L. Lan, J.D. Schuetz, and B.P. Sorrentino Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo Proc Natl Acad Sci U S A 99 2002 12339 12344
7. Y. An, and W.M. Ongkeko ABCG2: the key to chemoresistance in cancer stem cells? Exp Opin Drug Metab Toxicol 5 2009 1529 1542
8. J. Wang, L.P. Guo, L.Z. Chen, Y.X. Zeng, and S.H. Lu Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line Cancer Res 67 2007 3716 3724
9. P.S. Steyn The separation and detection of several mycotoxins by thin-layer chromatography J Chromatogr 45 1969 473 475
10. B.H. Wang, and G.M. Polya The fungal teratogen secalonic acid D is an inhibitor of protein kinase C and of cyclic AMP-dependent protein kinase Planta Med 62 1996 111 114
11. U.M. Hanumegowda, V.C. Dhulipala, and C.S. Reddy Mechanism of secalonic acid D-induced inhibition of transcription factor binding to cyclic AMP response element in the developing murine palate Toxicol Sci 70 2002 55 62
12. G. Liao, J. Zhou, H. Wang, Z. Mao, W. Xiao, and H. Wang The cell toxicity effect of secalonic acid D on GH3 cells and the related mechanisms Oncol Rep 23 2010 387 395
13. J.Y. Zhang, L.Y. Tao, Y.J. Liang, Y.Y. Yan, C.L. Dai, and X.K. Xia Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of GSK-3beta/beta-catenin/c-Myc pathway Cell Cycle 8 2009 2444 2450
14. 13C NMR assignments for two oxaphenalenones bacillosporin C and D from the mangrove endophytic fungus SBE-14 Magn Reson Chem: MRC 45 2007 439 441
15. J.Y. Zhang, H.Y. Wu, X.K. Xia, Y.J. Liang, Y.Y. Yan, and Z.G. She Anthracenedione derivative 1403P-3 induces apoptosis in KB and KBv200 cells via reactive oxygen species-independent mitochondrial pathway and death receptor pathway Cancer Biol Ther 6 2007 1413 1421
16. L. Fu, Y. Liang, L. Deng, Y. Ding, L. Chen, and Y. Ye Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance Cancer Chemother Pharmacol 53 2004 349 356
17. T. Sumizawa, Y. Chuman, H. Sakamoto, K. Iemura, K.C. Almquist, and R.G. Deeley Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein Somat Cell Mol Genet 20 1994 423 435
18. R.W. Robey, Y. Honjo, K. Morisaki, T.A. Nadjem, S. Runge, and M. Risbood Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity Br J Cancer 89 2003 1971 1978
19. L.M. Chen, X.P. Wu, J.W. Ruan, Y.J. Liang, Y. Ding, and Z. Shi Screening novel, potent multidrug-resistant modulators from imidazole derivatives Oncol Res 14 2004 355 362
20. L.Y. Tao, Y.J. Liang, F. Wang, L.M. Chen, Y.Y. Yan, and C.L. Dai Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function Cancer Chemother Pharmacol 64 2009 961 969
21. Z. Shi, Y.J. Liang, Z.S. Chen, X.W. Wang, X.H. Wang, and Y. Ding Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo Cancer Biol Ther 5 2006 39 47
22. M.A. Goodell, M. Rosenzweig, H. Kim, D.F. Marks, M. DeMaria, and G. Paradis Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Nat Med 3 1997 1337 1345
23. D. Liu, Z. Yan, R.D. Minshall, D.E. Schwartz, Y. Chen, and G. Hu Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury Am J Physiol Lung Cell Mol Physiol 302 2012 L370 L379
24. E.L. Volk, K.M. Farley, Y. Wu, F. Li, R.W. Robey, and E. Schneider Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance Cancer Res 62 2002 5035 5040
25. C. Hirschmann-Jax, A.E. Foster, G.G. Wulf, J.G. Nuchtern, T.W. Jax, and U. Gobel A distinct "side population" of cells with high drug efflux capacity in human tumor cells Proc Natl Acad Sci U S A 101 2004 14228 14233
26. K. Takubo, M. Ohmura, M. Azuma, G. Nagamatsu, W. Yamada, and F. Arai Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest Cell Stem Cell 2 2008 170 182
27. M.M. Eldeib, and C.S. Reddy Secalonic acid D-induced changes in palatal cyclic AMP and cyclic GMP in developing mice Teratology 37 1988 343 352
28. V.C. Dhulipala, K.K. Maddali, B.K. Ray, W.V. Welshons, and C.S. Reddy Role of p21 and cyclin E in normal and secalonic acid D-inhibited proliferation of human embryonic palatal mesenchymal cells Human Exp Toxicol 30 2011 1222 1232
29. R. Hong Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31 Pharm Biol 49 2011 796 799
30. Y. Wei, Y. Ma, Q. Zhao, Z. Ren, Y. Li, and T. Hou New use for an old drug: inhibiting ABCG2 with sorafenib Mol Cancer Therap 11 2012 1693 1702
31. R. Ding, J. Shi, K. Pabon, and K.W. Scotto Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance Mol Pharmacol 81 2012 328 337
32. H. Nakagawa, A. Tamura, K. Wakabayashi, K. Hoshijima, M. Komada, and T. Yoshida Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2 Biochem J 411 2008 623 631
33. S. Ohno, Y. Emori, S. Imajoh, H. Kawasaki, M. Kisaragi, and K. Suzuki Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein Nature 312 1984 566 570
34. R. Arakawa, and S. Yokoyama Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation J Biol Chem 277 2002 22426 22429
35. N. Wang, W. Chen, P. Linsel-Nitschke, L.O. Martinez, B. Agerholm-Larsen, and D.L. Silver A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I J Clin Invest 111 2003 99 107